跳至主要内容
临床试验/NCT05250622
NCT05250622已完成不适用

OrthoEvidence Trial Assessing Japanese Knowledge Updates : Trial of Knowledge Translation Among Japanese Surgeons

McMaster University2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2022年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
2
主要终点
Number of access to evidence summaries

研究概览

简要总结

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

详细描述

The investigators will conduct the survey regarding baseline characteristics, barriers and familiality to evidence-based medicine by online. After the survey, the participants will be randomly assigned to receive either the original version of ACE reports or Japanese version of ACE reports. The pdf of each ACE report will be provided to the participants through an email link. Twenty reports will be sent over 4 weeks period. After that, the investigators will conduct another survey regarding the reports.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Member of Japanese Society for Fracture Repair (JSFR)
  • Spend at least 20% of their time in clinical practice
  • Non-native speaker of English
  • Has regular access to internet
  • Prefer to read Japanese-translated material, if there are both translated and English version of the same material.

排除标准

  • We will exclude surgeons who cannot provide informed consent.

结局指标

主要结局

Number of access to evidence summaries

时间窗: Four weeks (28 days) after the commencement of the trial

Total number of access to evidence summaries

次要结局

  • Self-rated score of understanding the contents of the provided materials(Within four weeks after the end of intervention)
  • Self-rated score in changing their practice based on the contents of the materials(Within four weeks after the end of intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验